Three-Year quest to slow lung destruction in genetic emphysema
Disease control
Not yet recruiting
This study aims to find the most effective dose of an existing medication (Respreeza/Zemaira) to slow the progression of lung damage in adults with emphysema caused by Alpha-1 antitrypsin deficiency. Over 270 participants will receive weekly intravenous infusions for three years …
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC